, Tracking Stock Market Picks
Enter Symbol:
Intermune, Inc. (ITMN) [hlAlert]

up 122.72 %

Intermune, Inc. (ITMN) rated Buy with price target $45 by Goldman

Posted on: Tuesday,  Mar 11, 2014  8:25 AM ET by Goldman

Goldman rated Buy Intermune, Inc. (NASDAQ: ITMN) on 03/11/2014, when the stock price was $33.18. Since
then, Intermune, Inc. has gained 122.72% as of 09/26/2014's recent price of $73.90.
If you would have followed this Goldman's recommendation on ITMN, you would have gained 122.72% of your investment in 199 days.

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/11/2014 8:25 AM Buy
33.18 45.00
as of 10/17/2014
1 Week   
1 Month up  0.20 %
3 Months up  82.03 %
1 YTD up  122.69 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy